Epidemiology of systemic sclerosis in the Asia-Pacific region: a systematic review and meta-analysis by Ajanee Mahakkanukrauh, Chetta Ngamjarus, Porjai Pattanittum, Siraphop Suwannaroj, Patnarin Pongkulkiat, Tippawan Onchan, Chingching Foocharoen

Get full text

Diagnosis and treatment of interstitial lung disease in scleroderma systematica by L. P. Ananyeva

Get full text

Effects of interventions with resistance exercises on muscle strength, physical disability, and quality of life in systemic sclerosis patients: a systematic review with meta-analys... by André Luiz Silveira Mallmann, Daniel Nóbrega de Moraes, Lucas Denardi Dória, Leonardo Peterson dos Santos, Stephanie Pilotti, Mayra Angélica de Souza Antunes, Laura Fontana Steinmetz, Thauan Júnior Santos de Souza, Vanessa Hax, Jerri Luiz Ribeiro, Ricardo Machado Xavier, Rafael Mendonça da Silva Chakr

Get full text

Role of Vitamin D in Systemic Sclerosis: A Systematic Literature Review by Alexandra-Diana Diaconu, Iustina Ostafie, Alexandr Ceasovschih, Victorița Șorodoc, Cătălina Lionte, Codrina Ancuța, Laurențiu Șorodoc

“…Suboptimal vitamin D levels are classically recognized in scleroderma, irrespective of clinical and serological phenotype. …”
Get full text

General Diseases Influence on Peri-Implantitis Development: a Systematic Review by Zygimantas Guobis, Ingrida Pacauskiene, Inesa Astramskaite

“…Objectives: To systematically review the influence of systemic diseases or medications used in their treatment on the dental implant therapy success. …”
Get full text

Cutaneous presentations of systemic sclerosis in skin of colour: A systematic review by Alicia Podwojniak, Isabella J. Tan, Aliza Leiter, Hira Ghani, Bernard A. Cohen

“…A systematic review of the literature was conducted following PRISMA guidelines. …”
Get full text

Atopic Dermatitis and Autoimmune Connective Tissue Diseases: Systematic Review and Meta-Analysis by Somaia Naassan, Misbah Noshela Ghazanfar, Simon Francis Thomsen, Zarqa Ali

“…Objective: We aimed to conduct a systematic review and meta-analysis to assess the association between AD and ACTD. …”
Get full text

Adipose-derived mesenchymal stem cells and their derivatives in inflammatory skin diseases: a systematic review by Mateusz Matwiejuk, Agnieszka Mikłosz, Hanna Myśliwiec, Adrian Chabowski, Iwona Flisiak

“…It has been shown that ADMSC-derived exosomes can effectively alleviate pathological symptoms of atopic dermatitis, including clinical score, serum IgE levels, eosinophil amount, and infiltration of immune cells in skin lesions. This systematic review summarizes the most relevant preclinical and clinical studies on the therapeutic use of ADMSCs and their small extracellular vesicles in the treatment of common skin diseases like psoriasis, atopic dermatitis, localized scleroderma and acne vulgaris.…”
Get full text

The Clinical Efficacy and Safety of Nintedanib in the Treatment of Interstitial Lung Disease Among Patients With Systemic Sclerosis: Systematic Review by Khaled S. Al Oweidat, Ahmed A. Abdulelah, Ahmad A. Toubasi, Mohammad Abdulelah, Nour Z. Alatteili, Zaid A. Abdulelah

“…We searched PubMed, Scopus, and CENTRAL up to the first of September 2023 utilizing the following keywords: ((Diffuse Parenchymal Lung Disease) OR (Diffuse Parenchymal Lung Diseases) OR (Interstitial Lung Disease) OR (Interstitial Lung Diseases) OR (Interstitial Pneumonia) OR (Interstitial Pneumonitis) OR (Pulmonary Fibrosis)) AND ((Systemic Scleroderma) OR (Systemic Scleroderma)) AND ((BIBF 1120) OR (BIBF-1120) OR (BIBF1120) OR (Nintedanib esylate) OR (Ofev) OR (Vargatef)). …”
Get full text

Setting the international standard for longitudinal follow-up of patients with systemic sclerosis: a Delphi-based expert consensus on core clinical features by Yannick Allanore, Dinesh Khanna, Oliver Distler, Anna-Maria Hoffmann-Vold, Baron Murray, Otylia Kowal-Bielecka

“…All SSc experts from the European Scleroderma Trials and Research group network and the Scleroderma Clinical Trial Consortium were invited to participate. …”
Get full text

Technology forecast: advanced therapies in late clinical research, EMA approval or clinical application via hospital exemption by Claudia Eder, Claudia Wild

“…By 2020, innovative therapies targeting retinal dystrophy, ß-thalassemia, scleroderma, sickle-cell anaemia, adrenoleukodystrophy and leukaemia shall be available on the market.…”
Get full text

VULVAR AND VAGINAL GRAFT VERSUS HOST DISEASE IN A PATIENT WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION by Esra Pirinççi, M. Orhan Ayyıldız, Abdullah Karakuş, Reyhan Gündüz

“…A systematic approach is required, requiring close cooperation between gynecologists. …”
Get full text